- $691.97m
- $645.77m
- $111.47m
- 88
- 24
- 21
- 40
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 111 | 106 | 130 | 125 | 111 |
Cost of Revenue | |||||
Gross Profit | 70.5 | 66.5 | 81.5 | 78.3 | 68.4 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 89.4 | 79.1 | 94.9 | 94.5 | 85.7 |
Operating Profit | 21.9 | 26.7 | 35.1 | 31 | 25.8 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 22.9 | 26.6 | 35.1 | 31 | 27.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | 17.4 | 20 | 26.3 | 23.7 | 20.7 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 17.3 | 19.9 | 26.2 | 23.6 | 20.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 17.3 | 19.9 | 26.2 | 23.6 | 20.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.71 | 1.97 | 2.6 | 2.34 | 2.06 |
Dividends per Share | |||||
Special Dividends per Share |